A phase II study to evaluate the combination of fludarabine, mitoxantrone and dexamethasone (FMD) in patients with follicular lymphoma (Q74346087)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997815%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

A phase II study to evaluate the combination of fludarabine, mitoxantrone and dexamethasone (FMD) in patients with follicular lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997815%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997815%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

C R Crawley

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997815%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J M Foran

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997815%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

R K Gupta

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997815%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A Z Rohatiner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997815%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

K Summers

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997815%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J Matthews

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997815%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

I N Micallef

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997815%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

S A Johnson

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997815%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

P W Johnson

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997815%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J W Sweetenham

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997815%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

T A Lister

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997815%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 July 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997815%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997815%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997815%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997815%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

861-865

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997815%20AND%20SRC:MED&resulttype=core&format=json

Fludarabine phosphate for the treatment of low grade lymphoid malignancy

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008381105849

7 January 2021

Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008381105849

7 January 2021

Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008381105849

7 January 2021

Fludarabine: an active agent in the treatment of previously-treated and untreated low-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008381105849

7 January 2021

Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008381105849

7 January 2021

Treatment of indolent lymphoma with fludarabine/mitoxantrone combination: a phase II trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008381105849

7 January 2021

Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008381105849

7 January 2021

Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008381105849

7 January 2021

Fludarabine-mitoxantrone combination-containing regimen in recurrent low-grade non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008381105849

7 January 2021

Low-grade non-Hodgkin's lymphoma--development of a new effective combination regimen (fludarabine, mitoxantrone and dexamethasone; FND).

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008381105849

7 January 2021

Novel 5' exonuclease-based real-time PCR assay for the detection of t(14;18)(q32;q21) in patients with follicular lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008381105849

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008381105849

7 January 2021

A new effective treatment for indolent lymphoma: a pilot study with fludarabine, idarubicin and prednisone combination (FLIDA).

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008381105849

7 January 2021

Variability of polymerase chain reaction detection of the bcl-2-IgH translocation in an international multicentre study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008381105849

7 January 2021

BCL2 translocation frequency rises with age in humans

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008381105849

7 January 2021

Salvage chemotherapy using a combination of fludarabine and cyclophosphamide for refractory or relapsing indolent and aggressive non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008381105849

7 January 2021

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008381105849

7 January 2021

Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008381105849

7 January 2021

Identifiers

DOI

10.1023/A:1008381105849

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997815%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference